TY - JOUR
T1 - (2E,6Z,10E)-7-hydroxymethyl-3,11,15-trimethyl-2,6,10,14-hexadecatetraen-1- ol (plaunotol) increases cyclooxygenase-2 expression via nuclear factor κB and cyclic AMP response element in rat gastric epithelial cells
AU - Fu, Hai Ying
AU - Yabe, Yuki
AU - Asahi, Kayoko
AU - Hayashi, Yujiro
AU - Murata, Hiroaki
AU - Eguchi, Hiroshi
AU - Tsujii, Masahiko
AU - Tsuji, Shingo
AU - Kawano, Sunao
PY - 2005/11/7
Y1 - 2005/11/7
N2 - Plaunotol, [(2E,6Z,10E)-7-hydroxymethyl-3,11,15-trimethyl-2,6,10,14- hexadecatetraen-1-ol], a gastroprotective agent, increases the prostaglandin production in the gastric mucosa and accelerates ulcer healing. The precise mechanisms underlying the gastroprotective actions by plaunotol are not known. On the other hand, cyclooxygenase (COX)-2 is a key enzyme in PGE2 production and its induction is thought to have an important role in ulcer healing. We investigated the mechanism of plaunotol-mediated COX-2 induction in rat gastric epithelial (RGM1) cells. We used a PGE2 enzyme-linked immunoassay kit and Western blot analysis to measure PGE2 production and COX-2 induction with plaunotol treatment in serum-starved RGM1 cells. In addition, gel-shift assay, Western blot analysis and a reporter assay were performed to observe which Cox-2 promoter was involved in plaunotol-induced Cox-2 expression. The findings indicated that plaunotol treatment dose-dependently increased COX-2 expression and PGE2 production. The nuclear factor κB (NF-κB) and cyclic AMP response element (CRE) sites of the COX-2 gene promoter were critical to plaunotol-mediated COX-2 expression. In conclusion, plaunotol induced COX-2 expression and increased PGE2 production in serum-starved RGM1 cells via activation of the NF-κB and CRE sites of Cox-2 gene promoters.
AB - Plaunotol, [(2E,6Z,10E)-7-hydroxymethyl-3,11,15-trimethyl-2,6,10,14- hexadecatetraen-1-ol], a gastroprotective agent, increases the prostaglandin production in the gastric mucosa and accelerates ulcer healing. The precise mechanisms underlying the gastroprotective actions by plaunotol are not known. On the other hand, cyclooxygenase (COX)-2 is a key enzyme in PGE2 production and its induction is thought to have an important role in ulcer healing. We investigated the mechanism of plaunotol-mediated COX-2 induction in rat gastric epithelial (RGM1) cells. We used a PGE2 enzyme-linked immunoassay kit and Western blot analysis to measure PGE2 production and COX-2 induction with plaunotol treatment in serum-starved RGM1 cells. In addition, gel-shift assay, Western blot analysis and a reporter assay were performed to observe which Cox-2 promoter was involved in plaunotol-induced Cox-2 expression. The findings indicated that plaunotol treatment dose-dependently increased COX-2 expression and PGE2 production. The nuclear factor κB (NF-κB) and cyclic AMP response element (CRE) sites of the COX-2 gene promoter were critical to plaunotol-mediated COX-2 expression. In conclusion, plaunotol induced COX-2 expression and increased PGE2 production in serum-starved RGM1 cells via activation of the NF-κB and CRE sites of Cox-2 gene promoters.
KW - COX-2
KW - CRE
KW - Gastric epithelial cells
KW - NF-κB
KW - Plaunotol
UR - http://www.scopus.com/inward/record.url?scp=27744523457&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27744523457&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2005.09.044
DO - 10.1016/j.ejphar.2005.09.044
M3 - Article
C2 - 16253229
AN - SCOPUS:27744523457
SN - 0014-2999
VL - 524
SP - 38
EP - 43
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1-3
ER -